Harvard Bioscience (HBIO) Goodwill & Intangibles (2010 - 2026)

Harvard Bioscience (HBIO) has reported Goodwill & Intangibles for 17 consecutive years, with $69.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Goodwill & Intangibles rose 265.45% year-over-year to $69.8 million; the TTM figure through Mar 2026 stood at $69.8 million (up 265.45% YoY), while the FY2025 annual figure was $17.2 million, down 85.02% from the prior year.
• Goodwill & Intangibles advanced to $69.8 million in Q1 2026 per HBIO's latest filing, from $17.2 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $122.0 million in Q1 2022 and bottomed at $9.7 million in Q3 2025.
• Historically, Goodwill & Intangibles has averaged $72.0 million across 5 years, with a median of $69.8 million in 2024.
• Annual changes were most pronounced in 2025 — Goodwill & Intangibles sank 86.04% — and 2026, when it soared 265.45%.
• Harvard Bioscience's Goodwill & Intangibles stood at $56.5 million in 2022, then jumped by 104.88% to $115.7 million in 2023, then retreated by 0.82% to $114.8 million in 2024, then plunged by 85.02% to $17.2 million in 2025, then surged by 305.66% to $69.8 million in 2026.
• Business Quant data shows HBIO's Goodwill & Intangibles at $69.8 million in Q1 2026, $17.2 million in Q4 2025, and $9.7 million in Q3 2025.